Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: Results from humans and cholestatic rats

Hepatology

Volumn 45, Issue 2, 2007, Pages 331-339

  Grattagliano, Ignazio ^a   Portincasa, Piero ^a   Palmieri, Vincenzo O ^a   Palasciano, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; HYALURONIC ACID; NITRIC OXIDE; NITROSOTHIOL DERIVATIVE; THIOL DERIVATIVE; THIOREDOXIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; CELL PROLIFERATION; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; LIVER; LIVER INJURY; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RAT; STATISTICAL ANALYSIS;

ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CHOLESTASIS; ERYTHROCYTES; FEMALE; HUMANS; HYALURONIC ACID; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MITOCHONDRIA; NITRIC OXIDE; NITROGEN COMPOUNDS; PROTEINS; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; SULFHYDRYL COMPOUNDS; THIOREDOXIN;

EID: 33847790688     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21519     Document Type: Article

References (50)

1. Krahenbuhl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. HEPATOLOGY 1995;22:607-612.
2. Vendemiale G, Grattagliano I, Lupo I., Memeo V, Altomare E. Hepatic oxidative alterations in patients with extra-hepatic cholestasis: effect of surgical drainage. J Hepatol 2002;37:601-605.
3. Muriel P, Favari L, Soto C. Erythrocyte alterations correlate with CC14 and biliary obstruction-induced liver damage in the rat. Life Sci 1993;52:647-655.
4. Grattagliano I, Giudetti AM, Grattagliano V, Palmieri VO, Gnoni GV, Lapadula G, et al. Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: relation with the disease stage and effect of bile acid treatment. Eur J Clin Invest 2003;33:868-874.
5. Grattagliano I, Russmann S, Palmieri VO, Juni P, Bihl F, Portincasa P, et al. Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C. HEPATOLOGY 2004;391248-1255.
6. Arriero MM, Lopez-Farre A, Fryeiro O, Rodriguez-Feo JA, Velasco S, Garcia-Duran M, et al. Expression of inducible nitric oxide synthase in the liver of bile duct-ligated Wistar rats with modulation by lymphomono-nuclear cells. Surgery 2001;129:255-266.
7. McNaughton L, Puttagunta L, Martinez-Cuesta MA, Kneteman N, Mayers I Moqbel R, et al. Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci U S A 2002;99:17161-17166.
8. Hokari A, Zeniya M, Esumi H, Kawabe T, Gershwin ME, Toda G. Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury. J Gastroenterol Hepatol 2002;17:308-315.
9. Ottesen LH, Harry D, Frost M, Davies S, Khan K, Halliwell B, et al. Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic Biol Med 2001;31:790-798.
10. Sanz-Cameno P, Medina J, Garcia-Buey L, Garcia-Sanchez A, Borque MJ, Martin-Vilchez S, et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002;37:723-729.
11. Wu CT, Eiserich JP, Ansari AA, Coppel RL, Balasubramanian S, Bowlus CL, et al. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. HEPATOLOGY 2003;38:1018-1025.
12. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001;31:1287-1312.
13. Bindoli A, Rigobello MP. Mitochondrial thioredoxin reductase and thiol status. Methods Enzymol 2002;347:307-316.
14. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351-369.
15. Rigobello MP, Callegaro MT, Barzon E, Benetti M, Bindoli A. Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability. Free Radic Biol Med 1998;24:370-376.
16. Yoshida S, Katoh T, Tetsuka T, Uno K, Matsui N, Okamoto T. Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts. J Immunol 1999;163:351-358.
17. Bertini R, Howard OM, Dong HF, Oppenheim JJ, Bizzarri C, Sergi R, et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med 1999;189:1783-1789.
18. Nikitovic D, Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 1996;271:19180-19185.
19. Stoyanovsky DA, Tyurina YY, Tyurin VA, Anand D, Mandavia DN, Gius D, et al. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J Am Chem Soc 2005;127:15815-15823.
20. Grattagliano I, Portincasa P, Cocco T, Moschetta A, Di PM, Palmieri VO, et al. Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats. Exp Gerontol 2004;39:1323-1332.
21. Arnelle DR, Stamler JS. NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 1995;318:279-285.
22. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994;78:931-936.
23. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A 1992;89:7674-7677.
24. Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y, et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol 2003;38:32-38.
25. Albillos A, Rossi I, Cacho G, Martinez MV, Millan I, Abreu L, et al. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol 1995;268:G459-G464.
26. Scheuer P. Primary biliary cirrhosis. Proc R Soc Med 1967;60:1257-1260.
27. Hoppel C, DiMarco JP, Tandler B. Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J Biol Chem 1979;254:4164-4170.
28. Holmgren A, Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 1995;252:199-208.
29. Cook JA, Kim SY, Teague D, Krishna MC, Pacelli R, Mitchell JB, et al. Convenient colorimetric and fluorometric assays for S-nitrosothiols. Anal Biochem 1996;238:150-158.
30. Grattagliano I, Vendemiale G, Sabba C, Buonamico P, Altomare E. Oxidation of circulating proteins in alcoholics: role of acetaldehyde and xanthine oxidase. J Hepatol 1996;25:28-36.
31. Schmidt HH, Warner TD, Nakane M, Forstermann U, Murad F. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol 1992;41:615-624.
32. Mani AR, Ebrahimkhani MR, Ippolito S, Ollosson R, Moore KP. Metalloprotein-dependent decomposition of S-nitrosothiols: studies on the stabilization and measurement of S-nitrosothiols in tissues. Free Radic Biol Med 2006;40:1654-1663.
33. Mathews WR, Kerr SW. Biological activity of S-nitrosothiols: the role of nitric oxide. J Pharmacol Exp Ther 1993;267:1529-1537.
34. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. HEPATOLOGY 2002;35:478-491.
35. Nanji AA, Jokelainen K, Lau GK, Rahemtulla A, Tipoe GL, Polavarapu R, et al. Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration. J Pharmacol Exp Ther 2001;299:832-839.
36. Okuyama H, Nakamura H, Shimahara Y, Uyama N, Kwon YW, Kawada N, et al. Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. J Hepatol 2005;42:117-123.
37. Stumm MM, D'Orazio D, Sumanovski LT, Martin PY, Reichen J, Sieber CC. Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. Liver 2002;22:441-450.
38. Zimmermann H, Kurzen P, Klossner W, Renner EL, Marti U. Decreased constitutive hepatic nitric oxide synthase expression in secondary biliary fibrosis and its changes after Roux-en-Y choledocho-jejunostomy in the rat. J Hepatol 1996;25:567-573.
39. Esrefoglu M, Gul M, Emre MH, Polat A, Selimoglu MA. Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats. World J Gastroenterol 2005;11:1951-1956.
40. Zhang Y, Hogg N. S-Nitrosothiols: cellular formation and transport. Free Radic Biol Med 2005;38:831-838.
41. Brookes PS, Levonen AL, Shiva S, Sarti P, rley-Usmar VM. Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic Biol Med 2002;33:755-764.
42. Sahaf B, Heydari K, Herzenberg LA, Herzenberg LA. The extracellular micro-environment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects. Arch Biochem Biophys 2005;434:26-32.
43. Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A 1998;95:7631-7636.
44. Ghafourifar P, Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett 1997;418:291-296.
45. Steffen M, Sarkela TM, Gybina AA, Steele TW, Trasseth NJ, Kuehl D, et al. Metabolism of S-nitrosoglutathione in intact mitochondria. Biochem J 2001;356:395-402.
46. Carreras MC, Converso DP, Lorenti AS, Barbich M, Levisman DM, Jaitovich A, et al. Mitochondrial nitric oxide synthase drives redox signals for proliferation and quiescence in rat liver development. HEPATOLOGY 2004;40:157-166.
47. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003;299:896-899.
48. Krahenbuhl S. Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention. Pharmacol Ther 1993;60:1-38.
49. Chen T, Pearce LL, Peterson J, Stoyanovsky D, Billiar TR. Glutathione depletion renders rat hepatocytes sensitive to nitric oxide donor-mediated toxicity. HEPATOLOGY 2005;42:598-607.
50. Tu W, Kitade H, Satoi S, Zhang ZT, Kaibori M, Kwon AH, et al. Increased nitric oxide production in hepatocytes is involved in liver dysfunction following obstructive jaundice. J Surg Res 20021;106:31-36.